Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers

Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers

(2011) LiLi Jiang et al.   Molecular Cancer

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant

(2010) L Hu et al.   BRITISH JOURNAL OF CANCER

p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients

(2010) M. K. Y. Siu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients

(2009) Min Fei et al.   CANCER INVESTIGATION

Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion

(2009) Michelle K.Y. Siu et al.   INTERNATIONAL JOURNAL OF CANCER

Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment

(2009) Riccardo Di Fiore et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Functional Evidence that the Self-Renewal GeneNANOGRegulates Human Tumor Development

(2009) Collene R. Jeter et al.   STEM CELLS

Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis

(2008) Robert J. Kurman et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Overexpression of NANOG in Gestational Trophoblastic Diseases

(2008) Michelle K.Y. Siu et al.   AMERICAN JOURNAL OF PATHOLOGY

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

(2008) S. Zhang et al.   CANCER RESEARCH

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via  5-Integrin, which Is a Therapeutic Target

(2008) K. Sawada et al.   CANCER RESEARCH

Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma

(2008) S.-H. Chiou et al.   CLINICAL CANCER RESEARCH

Comparative epigenomics of human and mouse mammary tumors

(2008) Berna Demircan et al.   GENES CHROMOSOMES & CANCER

Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells

(2008) Lilly Y. W. Bourguignon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells

(2008) Silvia Fernández de Mattos et al.   MOLECULAR CANCER THERAPEUTICS

Cancer stem cell markers in common cancers – therapeutic implications

(2008) Thomas Klonisch et al.   TRENDS IN MOLECULAR MEDICINE